Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

High doses of rosemary extract can harm the liver, kidneys, and reproductive organs in young rats.

New understanding and treatments for hair loss are improving, but more research is needed.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss doesn't affect COVID-19 severity.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Long COVID causes various long-term health issues and needs better awareness and treatment.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.